TransCell Science

New York, United States Founded: 2011 • Age: 15 yrs Acquired By BioIVT
Novel drug assays from explant-derived human primary cells are developed.
Request Access

About TransCell Science

TransCell Science is a company based in New York (United States) founded in 2011 was acquired by BioIVT in March 2017.. TransCell Science operates in a competitive market with competitors including Kiyatec, Cellply, Lucid Scientific, CytoTronics and DiscoverX, among others.

  • Headquarter New York, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    BioIVT

    (Mar 09, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of TransCell Science

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in TransCell Science

TransCell Science has secured backing from 1 investor. Prominent investors backing the company include BioIVT. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Provider of in vitro diagnostic products and assay services
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by TransCell Science

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - TransCell Science

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Transcell Science Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of TransCell Science

TransCell Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kiyatec, Cellply, Lucid Scientific, CytoTronics and DiscoverX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
domain founded_year HQ Location
Developer of in-vitro diagnostic products for the detection of cancer
domain founded_year HQ Location
Real-time cell analyzers are developed for oxygen consumption monitoring.
domain founded_year HQ Location
Cell-based assays for drug discovery are developed via CMOS platform.
domain founded_year HQ Location
Develops cell-based assays and provides services for drug discovery and development.
domain founded_year HQ Location
3D cell culture products are developed for drug discovery applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Transcell Science

Frequently Asked Questions about TransCell Science

When was TransCell Science founded?

TransCell Science was founded in 2011.

Where is TransCell Science located?

TransCell Science is headquartered in New York, United States. It is registered at New York, New York, United States.

What does TransCell Science do?

TransCell Science is a provider of research and development services to industry and academia. It specializes in novel drug and biologics assays based on human primary cells grown from explant tissue. The company claims it to be more advantageous than cell lines, organ culture or animal models. It custom develops and manages complex projects for pharmaceutical, personal care companies, and leading academic and government institutions. The company got acquired by BioreclamationIVT on 9th March, 2017.

Who are the top competitors of TransCell Science?

TransCell Science's top competitors include CytoTronics, Kiyatec and Remedy Plan.

Who are TransCell Science's investors?

TransCell Science has 1 investor. Key investors include BioIVT.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available